As of Apr 20
| +0.0098 / +4.08%|
The 1 analysts offering 12-month price forecasts for Mateon Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +300.00% increase from the last price of 0.25.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.